11-Hydroxy-Delta-8-THC

11-Hydroxy-Delta-8-THC is a metabolite of Delta-8-THC, a variant of tetrahydrocannabinol (THC), which is one of the main active components of cannabis. It is produced in the body after the consumption of Delta-8-THC, and is believed to be responsible for some of the psychoactive effects associated with this compound.

Chemistry

11-Hydroxy-Delta-8-THC is a hydroxylated derivative of Delta-8-THC. The number '11' in its name refers to the position of the hydroxyl group on the THC molecule. This modification is believed to enhance the compound's ability to cross the blood-brain barrier, potentially increasing its psychoactive effects.

Pharmacology

The pharmacological effects of 11-Hydroxy-Delta-8-THC are not fully understood, as most research has focused on the more common Delta-9-THC and its metabolites. However, it is known that 11-Hydroxy-Delta-8-THC, like other forms of THC, acts as a partial agonist of the CB1 receptor and CB2 receptor, which are part of the endocannabinoid system in the human body.

Effects

The effects of 11-Hydroxy-Delta-8-THC are believed to be similar to those of other forms of THC, including feelings of euphoria, relaxation, and altered sensory perception. However, some users report that the effects are less intense and more clear-headed than those produced by Delta-9-THC.

Legal Status

The legal status of 11-Hydroxy-Delta-8-THC varies by country and in some cases, by state or province. In many jurisdictions, it is regulated in the same way as other forms of THC.

See Also

• Cannabinoid
• Endocannabinoid system
• Pharmacokinetics of cannabinoids

‎

‎